1. Home
  2. PRAX vs VAL Comparison

PRAX vs VAL Comparison

Compare PRAX & VAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$327.25

Market Cap

7.1B

Sector

Health Care

ML Signal

N/A

Logo Valaris Limited

VAL

Valaris Limited

N/A

Current Price

$79.12

Market Cap

6.4B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
PRAX
VAL
Founded
2015
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.4B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
PRAX
VAL
Price
$327.25
$79.12
Analyst Decision
Strong Buy
Hold
Analyst Count
21
9
Target Price
★ $650.00
$69.71
AVG Volume (30 Days)
420.7K
★ 826.7K
Earning Date
11-09-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 170.70
EPS
N/A
★ 1.14
Revenue
N/A
★ $2,369,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$41,442.59
$12.60
P/E Ratio
★ N/A
$70.47
Revenue Growth
N/A
★ 0.27
52 Week Low
$160.11
$48.09
52 Week High
$392.70
$114.12

Technical Indicators

Market Signals
Indicator
PRAX
VAL
Relative Strength Index (RSI) 63.91 37.85
Support Level $307.93 $72.13
Resistance Level $347.63 $81.10
Average True Range (ATR) 16.67 4.60
MACD 5.68 -2.39
Stochastic Oscillator 96.95 5.63

Price Performance

Historical Comparison
PRAX
VAL

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About VAL Valaris Limited

Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.

Share on Social Networks: